✦ LIBER ✦

Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia

✍ Scribed by Joseph Aquilina; Adrian Barnett; Olaleye Thompson; Kevin Harrington

Book ID: 113986396
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 129 KB
Volume: 181
Category: Article
ISSN: 1097-6868
DOI: 10.1016/s0002-9378(99)70448-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early Detection of Preeclampsia Using In

Early Detection of Preeclampsia Using Inhibin A and Other Second-Trimester Serum Markers

✍ Ree, Park Hea; Hahn, Won Bo; Chang, Sung Woon; Jung, Sang Hee; Kang, Jin Hee; Ch 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 463 KB

Role of second trimester maternal serum

Role of second trimester maternal serum markers as predictor of preeclampsia

✍ Meena Dayal; Parul Gupta; Manju Varma; U. K. Ghosh; Anudita Bhargava 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 85 KB

Leptin as a second trimester marker for

Leptin as a second trimester marker for preeclampsia

✍ Christopher Robinson (F); Donna Johnson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Inhibin A is a maternal serum marker for

Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester

✍ M Christiansen; B Nørgaard-Pedersen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Soluble endoglin as a second-trimester m

Soluble endoglin as a second-trimester marker for preeclampsia

✍ Christopher J. Robinson; Donna D. Johnson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 258 KB

COMBINING INHIBIN A WITH EXISTING SECOND

COMBINING INHIBIN A WITH EXISTING SECOND-TRIMESTER MARKERS IN MATERNAL SERUM SCREENING FOR DOWN'S SYNDROME

✍ H. S. CUCKLE; S. HOLDING; R. JONES; N. P. GROOME; E. M. WALLACE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 3 views

To assess the value of inhibin A as an additional second-trimester maternal serum marker of Down's syndrome we studied 56 affected and 280 unaffected pregnancies matched for gestational age. The median level in the cases was 1.62 multiples of the gestation-specific median (MOM) in the controls, with